Total trials
153
Active
35
Phase 3
5
Total enrollment
10,510
Pipeline matrix
Showing 22 of 22 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Early Dual IV Antibiotic Therapy - MRSA | — | — | — | — | — | 1 | |
| Early Dual IV Antibiotic Therapy - MSSA | — | — | — | — | — | 1 | |
| Single Agent IV Antibiotic Therapy - MRSA | — | — | — | — | — | 1 | |
| Single Agent IV Antibiotic Therapy - MSSA | — | — | — | — | — | 1 | |
| Xylitol Gum | — | — | — | — | — | 1 | |
| Cooled Sodium Chloride | — | — | — | — | — | 1 | |
| Warmed Sodium Chloride | — | — | — | — | — | 1 | |
| Pioglitazone 15mg | — | — | — | — | — | 1 | |
| Pioglitazone 30 mg | — | — | — | — | — | 1 | |
| Leflunomide 10mg | — | — | — | — | — | 1 | |
| Leflunomide 20mg | — | — | — | — | — | 1 | |
| Decitabine | — | — | — | — | — | 1 | |
| Subcutaneous Blinatumomab | — | — | — | — | — | 1 | |
| Eravacycline | — | — | — | — | — | 1 | |
| Hydroxychloroquine sulfate | — | — | — | — | — | 1 | |
| Daratumumab | — | — | — | — | — | 1 | |
| Calaspargase pegol-mknl | — | — | — | — | — | 1 | |
| Cannabidiol (CBD) Oil 300mg | — | — | — | — | — | 1 | |
| Cannabidiol (CBD) Oil 150mg | — | — | — | — | — | 1 | |
| 5% 5-fluorouracil (5-FU) powder | — | — | — | — | — | 1 | |
| 5% 5-fluorouracil | — | — | — | — | — | 1 | |
| HIPEC | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
- 2026-03
- 2026-12
- 2026-12
- 2027-01
- 2027-06
- 2027-07
- 2027-07
- 2027-10
- 2027-12
Top conditions
- Sleep Quality7
- Breast Cancer5
- Hypertension3
- Glaucoma3
- Obesity3
- Glioblastoma3
- Postpartum Disorder2
- Lung Cancer2
Frequently asked questions about West Virginia University
- How many clinical trials does West Virginia University have on ClinicalTrials.gov?
- West Virginia University is listed as the lead sponsor on 153 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of West Virginia University's trials are in Phase 3?
- 5 of West Virginia University's trials are in Phase 3, spread across 22 active drug programs.
- What therapeutic areas does West Virginia University focus on?
- West Virginia University's most-studied conditions on ClinicalTrials.gov are Sleep Quality, Breast Cancer, Hypertension, Glaucoma, Obesity.
- When are West Virginia University's next clinical trial readouts?
- West Virginia University has 10 upcoming primary-completion readouts tracked here; the soonest is “2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML”, expected around 2025-12-31.